U.S. Markets closed

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.3100-0.0500 (-0.9328%)
At close: 3:58PM EDT
People also watch
QDELOSURVIVORGENTGEN

Trinity Biotech plc

IDA Business Park
Bray
Ireland
353 1 276 9800
http://www.trinitybiotech.com

SectorHealthcare
IndustryDiagnostic Substances
Full Time Employees582

Key Executives

NameTitlePayExercisedAge
Mr. Ronan O’CaoimhCo-Founder, Chairman and Chief Exec. Officer788kN/A61
Mr. Kevin TansleyChief Financial Officer, Sec. and Director559kN/A46
Dr. James Walsh Ph.D.Bus. Devel. Director and Exec. Director240kN/A59
Dr. Eric Brouwer Ph.D.Chief Scientific Officer and VP CardiacN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease, sexually transmitted diseases, respiratory infections, epstein barr virus, and other viral pathogens; and products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a high risk of developing diabetes. It also develops, manufactures, and distributes products in the enzyme-linked immunosorbent, western blot, and cytotoxicity assay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. Further, it offers Uni-Gold S. pneumoniae, Uni-Gold Legionella, Uni-Gold C. difficile, and Uni-Gold Syphilis products. The company sells its products through its direct sales force in the United States; and a network of independent distributors and strategic partners internationally. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.

Corporate Governance

Trinity Biotech plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.